Petersen, Jan
Rossjohn, Jamie http://orcid.org/0000-0002-2020-7522
Funding for this research was provided by:
Australian Research Council
Article History
First Online: 27 June 2022
Competing interests
: The authors declare that they have a research collaboration with Immutep, a company exploring the use of targeting LAG3 in cancer immunotherapy.
Free to read: This content has been made available to all.